In Vitro and in Vivo Studies on the Transport of PEGylated Silica Nanoparticles across the Blood

In Vitro and in Vivo Studies on the Transport of PEGylated Silica Nanoparticles across the Blood–Brain Barrier

Published:2014-01-17 Issue:3 Volume:6 Page:2131-2136
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Liu Dan¹,Lin Bingqian¹,Shao Wei¹,Zhu Zhi¹,Ji Tianhai¹,Yang Chaoyong¹

Affiliation:

1. Affiliated Chenggong Hospital, State Key Laboratory of Physical Chemistry of Solid Surfaces, the Key Laboratory for Chemical Biology of Fujian Province, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, People’s Republic of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/am405219u

Reference50 articles.

1. The blood–brain barrier: an overview

2. Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation

3. A novel chemical delivery system for brain targeting

4. Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7

5. P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Restrict Brain Accumulation of the Active Sunitinib MetaboliteN-Desethyl Sunitinib

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and toxicity of inorganic nanoparticles and the physicochemical properties/factors affecting them;Journal of Drug Delivery Science and Technology;2024-09

2. Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease;Frontiers in Pharmacology;2024-05-24

3. Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier;ACS Nano;2024-05-08

4. Overcoming the Blood–Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma;ACS Applied Materials & Interfaces;2024-04-17

5. Silica Nanoparticles Decrease Glutamate Uptake in Blood–Brain Barrier Components;Neurotoxicity Research;2024-03-04